
TY  - JOUR
AU  - Malchesky, Paul S.
TI  - Artificial Organs 2015: A Year in Review
JO  - Artificial Organs
JA  - Artif Organs
VL  - 40
IS  - 3
SN  - 0160-564X
UR  - https://doi.org/10.1111/aor.12707
DO  - doi:10.1111/aor.12707
SP  - 294
EP  - 321
KW  - Apheresis
KW  - Auditory support
KW  - Bioengineering
KW  - Blood pumps
KW  - Cardiac support
KW  - Cardiopulmonary
KW  - Dermal
KW  - Dialysis
KW  - Functional electrical stimulation
KW  - Medical devices
KW  - Membrane oxygenation
KW  - Organ preservation
KW  - Orthopedic
KW  - Pulmonary
KW  - Renal
KW  - Surgery
KW  - Tissue engineering
KW  - Transplantation
KW  - Valves
KW  - Vascular
KW  - Vision
PY  - 2016
AB  - Abstract In this Editor's Review, articles published in 2015 are organized by category and briefly summarized. We aim to provide a brief reflection of the currently available worldwide knowledge that is intended to advance and better human life while providing insight for continued application of technologies and methods of organ Replacement, Recovery, and Regeneration. As the official journal of The International Federation for Artificial Organs, The International Faculty for Artificial Organs, the International Society for Rotary Blood Pumps, the International Society for Pediatric Mechanical Cardiopulmonary Support, and the Vienna International Workshop on Functional Electrical Stimulation, Artificial Organs continues in the original mission of its founders ?to foster communications in the field of artificial organs on an international level.? Artificial Organs continues to publish developments and clinical applications of artificial organ technologies in this broad and expanding field of organ Replacement, Recovery, and Regeneration from all over the world. We take this time also to express our gratitude to our authors for providing their work to this journal. We offer our very special thanks to our reviewers who give so generously of their time and expertise to review, critique, and especially provide meaningful suggestions to the author's work whether eventually accepted or rejected. Without these excellent and dedicated reviewers, the quality expected from such a journal could not be possible. We also express our special thanks to our Publisher, John Wiley & Sons for their expert attention and support in the production and marketing of Artificial Organs. We look forward to reporting further advances in the coming years.
ER  - 

TY  - JOUR
AU  - MOULOPOULOS, S.D.
TI  - Dr. WILLEM J. KOLFF‘ CONTRIBUTIONS
JO  - Artificial Organs
VL  - 17
IS  - 6
SN  - 0160-564X
UR  - https://doi.org/10.1111/j.1525-1594.1993.tb00439.x
DO  - doi:10.1111/j.1525-1594.1993.tb00439.x
SP  - 392
EP  - 450
PY  - 1993
ER  - 

TY  - JOUR
TI  - METABOLIC AND CRYSTAL ARTHROPATHIES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_15.x
DO  - doi:10.1111/j.1479-8077.2006.00199_15.x
SP  - A83
EP  - A90
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOARTHRITIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_19.x
DO  - doi:10.1111/j.1479-8077.2006.00199_19.x
SP  - A108
EP  - A125
PY  - 2006
ER  - 

TY  - JOUR
TI  - ANTI-PHOSPHOLIPID SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_2.x
DO  - doi:10.1111/j.1479-8077.2006.00199_2.x
SP  - A25
EP  - A26
PY  - 2006
ER  - 

TY  - JOUR
TI  - PAEDIATRIC RHEUMATOLOGY
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_22.x
DO  - doi:10.1111/j.1479-8077.2006.00199_22.x
SP  - A159
EP  - A167
PY  - 2006
ER  - 

TY  - JOUR
TI  - RHEUMATOID ARTHRITIS – TREATMENT
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_24.x
DO  - doi:10.1111/j.1479-8077.2006.00199_24.x
SP  - A188
EP  - A210
PY  - 2006
ER  - 

TY  - JOUR
TI  - SJOGREN'S SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_27.x
DO  - doi:10.1111/j.1479-8077.2006.00199_27.x
SP  - A230
EP  - A234
PY  - 2006
ER  - 

TY  - JOUR
TI  - Vllth World Congress of the International Society for Artificial Organs
JO  - Artificial Organs
VL  - 14
IS  - 2
SN  - 0160-564X
UR  - https://doi.org/10.1111/j.1525-1594.1990.tb01608.x
DO  - doi:10.1111/j.1525-1594.1990.tb01608.x
SP  - 130
EP  - 166
PY  - 1990
ER  - 

C7  - pp. 309-329
TI  - Index
SN  - 9780470410110
UR  - https://doi.org/10.1002/9780470891193.index
DO  - doi:10.1002/9780470891193.index
SP  - 309-329
PY  - 1990
ER  - 

TY  - JOUR
TI  - 2017 Scientific Program
JO  - Journal of Ultrasound in Medicine
JA  - J Ultrasound Med
VL  - 36
IS  - S1
SN  - 9780470410110
UR  - https://doi.org/10.1002/jum.14288
DO  - doi:10.1002/jum.14288
SP  - S1
EP  - S135
PY  - 2017
ER  - 

TY  - JOUR
TI  - HEALTH SERVICES, ECONOMICS AND OUTCOME MEASURES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9780470410110
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_12.x
DO  - doi:10.1111/j.1479-8077.2006.00199_12.x
SP  - A68
EP  - A78
PY  - 2006
ER  - 

TY  - JOUR
TI  - HUMORAL ASPECTS OF AUTOIMMUNE DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9780470410110
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_13.x
DO  - doi:10.1111/j.1479-8077.2006.00199_13.x
SP  - A79
EP  - A80
PY  - 2006
ER  - 

TY  - JOUR
TI  - OTHERS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9780470410110
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_21.x
DO  - doi:10.1111/j.1479-8077.2006.00199_21.x
SP  - A142
EP  - A159
PY  - 2006
ER  - 

TY  - JOUR
TI  - SYSTEMIC LUPUS ERYTHEMATOSUS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9780470410110
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_30.x
DO  - doi:10.1111/j.1479-8077.2006.00199_30.x
SP  - A253
EP  - A274
PY  - 2006
ER  - 

TY  - JOUR
TI  - VASCULITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9780470410110
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_31.x
DO  - doi:10.1111/j.1479-8077.2006.00199_31.x
SP  - A274
EP  - A278
PY  - 2006
ER  - 

TY  - JOUR
TI  - Basic science: The cutting edge in optical diagnostics and therapeutics of tissues and cells
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 36
IS  - S17
SN  - 9780470410110
UR  - https://doi.org/10.1002/lsm.20162
DO  - doi:10.1002/lsm.20162
SP  - 1
EP  - 16
PY  - 2005
ER  - 

TY  - JOUR
C7  - e26772
TI  - SIOP ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 64
IS  - S3
SN  - 9780470410110
UR  - https://doi.org/10.1002/pbc.26772
DO  - doi:10.1002/pbc.26772
SP  - e26772
PY  - 2017
ER  - 

TY  - JOUR
AU  - Tislér,             A.
AU  - Akócsi, K. 
AU  - Borbás, B.
AU  - Fazakas, L.
AU  - Ferenczi, S.
AU  - Görögh, S.
AU  - Kulcsár, I.
AU  - Nagy, L.
AU  - Sámik, J.
AU  - Szegedi, J.
AU  - Tóth, E.
AU  - Wágner, G.
AU  - Kiss, I.
TI  - The Effect of Frequent and Occasional Dialysis-Associated Hypotension on Survival of Patients on Hemodialysis
JO  - Hemodialysis International
VL  - 8
IS  - 1
SN  - 9780470410110
UR  - https://doi.org/10.1111/j.1492-7535.2004.0085ah.x
DO  - doi:10.1111/j.1492-7535.2004.0085ah.x
SP  - 91
EP  - 91
PY  - 2004
AB  - Frequent or occasional symptomatic intradialytic hypotension during hemodialysis may influence patients' well being, but its effects on survival, independent of comorbidities, have not previously been investigated. Objective:? To assess the effect of frequent (f-IDH) or occasional (o-IDH) dialysis-associated hypotension on survival. Methods:? During the run in period in 1998, 77 patients with f-IDH (≥10 hypotensive events/10 months, responding only to medical intervention) and 101 patients with o-IDH (1 or 2 events/10 months) were identified among all 958 prevalent chronic hemodialysis patients of a network. Eighty-five patients who had no hypotensive episodes (no-IDH) served as controls. Patients were followed for a median of 27 months (range 0.3?37), and survival of patients was compared by log-rank test. Independent association of f-IDH and o-IDH on survival, compared to no-IDH, was assessed by proportional hazards model that included patient's demographics, laboratory data, comorbidity as well as medications. Results:? Forty-five patients (58%) with f-IDH, 47 (47%) with o-IDH, and 33 (39%) with no-IDH died during the follow up that represents mortality rates of 37 (p?=?0.013 vs. no-IDH), 26 (p =?0.375 vs. no-IDH), and 21 deaths/100?patient years in the three groups, respectively. In multivariate proportional hazards regression, where age, sex, time on dialysis, CHD, diabetes, Kt/V, albumin level, use of beta-blockers, calcium-channel blockers, and long-acting nitrates have been adjusted for, neither f-IDH nor o-IDH was associated with survival. Conclusion:? Mortality in patients with f-IDH is significantly higher than in those without such events. Our data, however, did not provide evidence that f-IDH, independent of age and comorbidities, contributes to mortality in these patients.
ER  - 

TY  - JOUR
AU  - George, C.
AU  - Jones, L.L.
AU  - Johnson, S.L.
AU  - Andrews, W.S.
AU  - Warady, B.A.
TI  - Central Venous Catheter Access in Children on HD
JO  - Hemodialysis International
VL  - 8
IS  - 1
SN  - 9780470410110
UR  - https://doi.org/10.1111/j.1492-7535.2004.0085bw.x
DO  - doi:10.1111/j.1492-7535.2004.0085bw.x
SP  - 106
EP  - 107
PY  - 2004
AB  - Central venous catheters (CVC) remain a frequently used form of vascular access in children receiving chronic hemodialysis (HD). Whereas standard dual-lumen catheters (DL) are used in many centers, the Tesio catheter has proven to be superior to the DL catheter in terms of catheter survival and infection rates in at least one pediatric study (Sheth RD et al. Am J Kidney Dis. 2001). Recently, the Ash Split catheter became available which, while similar to the Tesio internally, being comprised of 2 separate catheters, may be preferable because of the requirement for only one skin puncture for placement vs. two for the Tesio. However, no pediatric data pertaining to the Ash Split catheter have been published to date. Therefore, we reviewed and compared our experience with a small number of Ash Split (# 16) and Tesio (# 8) catheters used for semipermanent vascular access in our chronic HD population with reference to survival, infectious complications, patency, and dialysis adequacy. The results of this experience are as follows: Tesio Ash Split Survival >3 months 6/8 12/15 Sepsis (epi/catheter mo) 1/30 1/25 Exit-site infection (epi/catheter mo) 1/8.6 1/19 sp Kt/V urea 1.67 1.88 % sp Kt/V urea >1.2 100 90 Reasons for the removal of Tesio catheters were transplant (4), sepsis (1), deterioration of tubing (1), and accidental (1). Ash Split catheter removal resulted from sepsis (2), fistula placement (4), thrombosis (1), and accidental (2). This preliminary experience reveals similar outcome data for the Tesio and Ash Split catheters when used in pediatric HD patients. Definitive statements regarding the superiority of either catheter awaits additional data collection and analysis.
ER  - 
